✦ LIBER ✦

Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study

✍ Scribed by Langley, J. M.; Risi, G.; Caldwell, M.; Gilderman, L.; Berwald, B.; Fogarty, C.; Poling, T.; Riff, D.; Baron, M.; Frenette, L.; Sheldon, E.; Collins, H.; Shepard, M.; Dionne, M.; Brune, D.; Ferguson, L.; Vaughn, D.; Li, P.; Fries, L.

Book ID: 121658988
Publisher: University of Chicago Press
Year: 2011
Tongue: English
Weight: 329 KB
Volume: 203
Category: Article
ISSN: 0022-1899
DOI: 10.1093/infdis/jir172

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of an MF59®-ad

Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly

✍ Timo Vesikari; Aino Forstén; Karl-Heinz Herbinger; Giovanni Della Cioppa; Jenny 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB

Safety and immunogenicity of a virus-lik

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

✍ Constantino López-Macías; Eduardo Ferat-Osorio; Alejandra Tenorio-Calvo; Armando 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 721 KB

A Phase III, randomized study to evaluat

A Phase III, randomized study to evaluate the immunogenicity and safety of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in HIV-positive adults

✍ Diaz, Ricardo Sobhie; Tenore, Simone Barros; da Silva, Mônica M. Gomes; da Cunha 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 515 KB

Priming for Pandemic Influenza: Antigen-

Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly

✍ V.F.H. Brauer; F. Laghi-Pasini; P.L. Capecchi; C. Gentile; P. di Giovanni; T. St 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A randomized clinical trial to identify

A randomized clinical trial to identify the optimal antigen and MF59® adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects

✍ Christoph Hatz; Frank von Sonnenburg; Daniela Casula; Maria Lattanzi; Geert Lero 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 668 KB

Safety and immunogenicity of a trivalent

Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: A phase III open-label single-arm study

✍ M. Loebermann; G. Anders; G. Brestrich; C. Fritzsche; S. Klammt; D. Boršo; S. Fr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 267 KB